Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Updated advice on lactating cow intramammary antibiotics
The VMD was informed of supply problems with certain lactating cow antibiotics earlier this year.

Multiject IMM Intramammary Suspension will arrive January 2021.

The Veterinary Medicines Directorate (VMD) has updated its advice on the availability of lactating cow intramammary antibiotics.

Earlier this year, the VMD were informed by Marketing Authorisation Holders (MAHs) of supply problems with certain lactating cow intramammary antibiotics.

On Tuesday (18 August) the list of anticipated resolution dates was updated. Combiclav Intramammary Suspension for Lactating Cows is now expected November 2020 while Multiject IMM Intramammary Suspension will arrive January 2021.

The full list is as follows:

Product Anticipated Resolution Date
Synulox Lactating Cow Intramammary Suspension (42058/4143) October-December 2020
Tetra-Delta Intramammary Suspension (42058/4152) October-December 2020
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) January 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035)  End of July 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534)  End of June 2020
Cobactan MC Intramammary Suspension for Lactating Cows (42810/4000 End of June 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424)  November 2020

The following lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)

Further details on the supply situation for individual UK-authorised product can be obtained through the MAH or a wholesale dealer.

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.